Glaucoma Articles

This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.

CLEAR
New Contact Lens Technology Could Change The Lives Of Glaucoma Patients

New Contact Lens Technology Could Change the Lives of Glaucoma Patients

Arrow Right
New contact lens technologies could make it easier for patients to comply with their medication plans and monitor both the progress of the disease and the efficacy of newly prescribed drugs.
Curing Glaucoma-Related Vision Loss With High-Contrast Visual Stimulation

Curing Glaucoma-related Vision Loss with High-contrast Visual Stimulation

Arrow Right
A research study has found that high-contrast visual activity promotes optic nerve regrowth.
Research Into Nerve Growth Factor For Glaucoma Offers New Hope For Treatment

Research into Nerve Growth Factor for Glaucoma Offers New Hope for Treatment

Arrow Right
Nerve regeneration focuses on ways to regrow nerves. Neuroprotection is preventing the death of nerve cells. Both goals must be developed before vision loss due to glaucoma can be stopped or reversed.
Saving Sight In Glaucoma: Why The Brain May Hold The Key

Saving Sight in Glaucoma: Why the Brain May Hold the Key

Arrow Right
What causes vision loss in glaucoma? First is elevated ocular pressure, and second is damage to the optic nerve, which is the structure that sends visual information to the brain.
New Research Holds Promise For Restoring Lost Vision

New Research Holds Promise For Restoring Lost Vision

Arrow Right
Stanford researchers, funded in part by the National Eye Institute and the Glaucoma Research Foundation, make discovery that may help glaucoma patients who have lost vision.
Grf Scientific Advisors On Collaborative Research

GRF Scientific Advisors on Collaborative Research

Arrow Right
Members of our Scientific Advisory Board talk about the success of the Catalyst for a Cure collaborative research model.
Future Focus: Stem Cell Treatment For Glaucoma

Future Focus: Stem Cell Treatment for Glaucoma

Arrow Right
Stem cells are undifferentiated cells which have the potential to develop into many different types of specialized tissues.
Ocular Hypertension Treatment

Ocular Hypertension Treatment

Arrow Right
There are millions of people in the United States who have increased pressure in their eyes (intraocular pressure) without glaucoma. Often this condition is referred to as ocular hypertension.
Catalyst For A Cure: Glaucoma Biomarker To Be Tested

Catalyst for a Cure: Glaucoma Biomarker to Be Tested

Arrow Right
The Catalyst for a Cure (CFC) Biomarker Initiative brings together four research laboratories to find new and sensitive measures for glaucoma.
Restoring Vision: Retinal Nerve Cell Regeneration

Restoring Vision: Retinal Nerve Cell Regeneration

Arrow Right
Researchers have made great progress in understanding the process of optic nerve degeneration and regeneration in glaucoma.
Glaucoma And The Brain

Glaucoma and the Brain

Arrow Right
Researchers now view glaucoma as a disease of the brain — a neurodegenerative disease — rather than simply an eye disease.
Early Retina Cell Changes In Glaucoma Identified

Early Retina Cell Changes in Glaucoma Identified

Arrow Right
A study published by Andrew D. Huberman, PhD and Rana N. El-Danaf, PhD points to the specific structural features and cell types in the retina that may act as key factors in glaucoma progression.
Can Glaucoma Be Cured?

Can Glaucoma Be Cured?

Arrow Right
We hope to one day restore vision lost from glaucoma, but that can’t presently be done.
Dr. Derek S. Welsbie Awarded The 2014 Shaffer Prize For Innovative Glaucoma Research

Dr. Derek S. Welsbie awarded the 2014 Shaffer Prize for Innovative Glaucoma Research

Arrow Right
Derek Welsbie, MD, PhD was awarded the 2014 Shaffer Prize for Innovative Glaucoma Research for his study “Evaluating the Role of the c-Jun N-terminal Kinase Cascade in Retinal Ganglion Cell Death.”
Calkins Team Tracking New Options To Treat Glaucoma

Calkins Team Tracking New Options to Treat Glaucoma

Arrow Right
“We believe this is an important step toward a new and powerful treatment option for glaucoma patients who are going blind despite efforts to lower or manage their eye pressure.” — David Calkins, PhD
Regenerating Lost Vision In Glaucoma

Regenerating Lost Vision in Glaucoma

Arrow Right
What can we do when patients have lost functional vision in glaucoma?
Catalyst For A Cure Research Progress 2013

Catalyst for a Cure Research Progress 2013

Arrow Right
Catalyst for a Cure is a unique approach to research developed by Glaucoma Research Foundation to accelerate the pace of discovery toward a cure for glaucoma.
Interview With Glaucoma Researcher Tonia Rex, Phd

Interview with Glaucoma Researcher Tonia Rex, PhD

Arrow Right
GRF awarded Dr. Tonia Rex the Shaffer Prize for Innovative Glaucoma Research in 2012 for her project investigating a neuroprotective therapy in a model of inherited glaucoma.
Biomarkers For Glaucoma

Biomarkers for Glaucoma

Arrow Right
What is a biomarker? A biomarker is an indicator of a biological condition that, in some cases, can assist in the diagnosis and management of disease.
What Causes Vision Loss In Glaucoma?

What Causes Vision Loss in Glaucoma?

Arrow Right
Researchers hope that by studying other neurodegenerative diseases, we can identify common causes that will help us develop new treatments for glaucoma.
Eye Drops May Delay Or Prevent Glaucoma In African Americans

Eye Drops May Delay or Prevent Glaucoma in African Americans

Arrow Right
Eye drops that reduce elevated pressure inside the eye can delay or possibly prevent the onset of glaucoma in African Americans at higher risk for developing the disease, researchers have found.
Catalyst For A Cure Roundtable (Cfc1)

Catalyst for a Cure Roundtable (CFC1)

Arrow Right
These videos with the Catalyst for a Cure researchers were filmed during a roundtable interview discussion in January 2011 at the Palace Hotel in San Francisco.
Catalyst For A Cure (Cfc1) Report: Nine Years Of Innovation

Catalyst for a Cure (CFC1) Report: Nine Years of Innovation

Arrow Right
The Catalyst For a Cure has reshaped the direction of glaucoma research by taking a pioneering approach that should become a model for research in other diseases.
Catalyst For A Cure 2011 Progress Report

Catalyst for a Cure 2011 Progress Report

Arrow Right
The research team identified a period of vulnerability for retinal ganglion cells early in the disease, when these cells are more sensitive to metabolic insults and stressors.
Catalyst For A Cure Identifies Key Early Events In Glaucoma

Catalyst for a Cure Identifies Key Early Events in Glaucoma

Arrow Right
During the year 2009, the investigators of the Catalyst for a Cure (CFC1) consortium worked together to probe how retinal ganglion cells are damaged and decline in glaucoma.